1. Artificial intelligence supports automatic coding of ADR reports

   Clinical study 21 May 2022 Pages: 1 - 1

2. New formulation of COMIRNATY requires no dilution

   Unknown 21 May 2022 Pages: 2 - 2

3. ADRs due to off-label use of hydroxychloroquine for COVID-19

   Clinical study 21 May 2022 Pages: 3 - 3

4. ADRs with bivalirudin as anticoagulant during PCI

   Clinical study 21 May 2022 Pages: 4 - 4

5. Anti-obesity drug AEs more common with phentermine and liraglutide

   Clinical study 21 May 2022 Pages: 5 - 5

6. Antifungal drug-induced liver injury

   Clinical study 21 May 2022 Pages: 6 - 6

7. Aspirin reduces risk of MACE but increases risk of haemorrhage

   Clinical study 21 May 2022 Pages: 7 - 7

8. Morphine use increases risk of reinfarction after STEMI

   Clinical study 21 May 2022 Pages: 8 - 8

9. Nitrofurantoin-related haemolytic anaemia in G6PD deficiency

   Clinical study 21 May 2022 Pages: 9 - 9

10. NSAIDs plus oral anticoagulants: increased risk of haemorrhage

    Clinical study 21 May 2022 Pages: 10 - 10

11. Risk of ADR re-admission after ADR-related hospitalisation

    Clinical study 21 May 2022 Pages: 11 - 11

12. Survey of adverse events following ChAdOx1 COVID-19 vaccination in Ethiopia

    Clinical study 21 May 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 21 May 2022 Pages: 13 - 13

14. Acarbose/imipramine/pseudoephedrine

    Case report 21 May 2022 Pages: 14 - 14

15. Acetazolamide/bromfenac/prednisolone-acetate

    Case report 21 May 2022 Pages: 15 - 15

16. Acetyl tyrosine/alpha ketoglutarate/arginine/ascorbic acid/beta alanine/caffeine/cobalamin/creatine/folic acid/mucuna pruiens/niacin/pyridoxine/theacrine overdose

    Case report 21 May 2022 Pages: 16 - 16

17. Aciclovir

    Case report 21 May 2022 Pages: 17 - 17

18. Aciclovir

    Case report 21 May 2022 Pages: 18 - 18

19. Aciclovir/bortezomib/famciclovir

    Case report 21 May 2022 Pages: 19 - 19

20. Acitretin

    Case report 21 May 2022 Pages: 20 - 20

21. Acitretin

    Case report 21 May 2022 Pages: 21 - 21

22. Acitretin/immunosuppressants/unspecified steroids

    Case report 21 May 2022 Pages: 22 - 22

23. Ad26.COV2-S

    Case report 21 May 2022 Pages: 23 - 23

24. Ad26.COV2-S

    Case report 21 May 2022 Pages: 24 - 24

25. Adalimumab

    Case report 21 May 2022 Pages: 25 - 25

26. Adalimumab/infliximab

    Case report 21 May 2022 Pages: 26 - 26

27. Adalimumab/ixekizumab/methotrexate

    Case report 21 May 2022 Pages: 27 - 27

28. Aflibercept/bevacizumab/ranibizumab

    Case report 21 May 2022 Pages: 28 - 28

29. Alemtuzumab

    Case report 21 May 2022 Pages: 29 - 29

30. Amiodarone

    Case report 21 May 2022 Pages: 30 - 30

31. Amiodarone/metoclopramide/neostigmine

    Case report 21 May 2022 Pages: 31 - 31

32. Amphotericin B

    Case report 21 May 2022 Pages: 32 - 32

33. Amphotericin-B-liposomal

    Case report 21 May 2022 Pages: 33 - 33

34. Amphotericin-B-liposomal

    Case report 21 May 2022 Pages: 34 - 34

35. Amphotericin-b-liposomal/fluconazole/metformin

    Case report 21 May 2022 Pages: 35 - 35

36. Amphotericin-B-liposomal/glucocorticoids

    Case report 21 May 2022 Pages: 36 - 36

37. Amphotericin-B/flucytosine/prednisone

    Case report 21 May 2022 Pages: 37 - 37

38. Anakinra

    Case report 21 May 2022 Pages: 38 - 38

39. Anakinra/prednisolone

    Case report 21 May 2022 Pages: 39 - 39

40. Anti-inflammatories/hydroxychloroquine

    Case report 21 May 2022 Pages: 40 - 40

41. Antibacterials

    Case report 21 May 2022 Pages: 41 - 41

42. Antibacterials

    Case report 21 May 2022 Pages: 42 - 42

43. Antibacterials

    Case report 21 May 2022 Pages: 43 - 43

44. Antibacterials

    Case report 21 May 2022 Pages: 44 - 44

45. Antibacterials/immunosuppressants

    Case report 21 May 2022 Pages: 45 - 45

46. Antiepileptic drugs

    Case report 21 May 2022 Pages: 46 - 46

47. Antiepileptic drugs

    Case report 21 May 2022 Pages: 47 - 47

48. Antiepileptics/enalapril/norepinephrine

    Case report 21 May 2022 Pages: 48 - 48

49. Antigouts

    Case report 21 May 2022 Pages: 49 - 49

50. Antihyperglycaemics

    Case report 21 May 2022 Pages: 50 - 50